Assessment of the clinical benefits of prenatal screening for toxoplasmosis in southern Taiwan

Taiwan J Obstet Gynecol. 2022 Sep;61(5):830-836. doi: 10.1016/j.tjog.2021.08.008.

Abstract

Objective: The present study aimed to investigate the seroprevalence and risk factors for toxoplasmosis among pregnant women in southern Taiwan and to determine the clinical benefits of screening for the same.

Materials and methods: The current study included 458 pregnant women who received prenatal care from the first trimester at the Kaohsiung and Chiayi Chang Gung Memorial Hospitals during the time period from 2014 to 2015. Serological tests performed to detect the presence of Toxoplasma IgG and IgM antibodies. Amniocentesis was scheduled and real-time polymerase chain reaction (PCR) was employed to detect Toxoplasma DNA. Moreover, the maternal characteristics and risk factors, perinatal outcomes related to the seropositivity for Toxoplasma infection were analyzed.

Results: Among the pregnant patients included in the current study, 39/458 (8.5%) were IgG+ and 2/458 (0.6%) were IgM+. The present study analyzed the maternal characteristics and risk factors, perinatal outcome pertaining to the IgG seropositive group by means of the multiple logistic regression analysis revealed a female predominance (10.8%), compared to the males (6.4%), (adjusted OR = 0.48 (95%, 0.24-0.98), P = 0.043∗). The number cases with gestational age above 37 weeks at the time of delivery was significantly lower, compared to the cases below 37 weeks (adjusted OR = 0.32 (0.12-0.94), P = 0.038∗). Among one case with low avidity cannot exclude recent infection, the amniocentesis did not show any evidence of vertical transmission.

Conclusion: The scenario may not warrant general screening and the results will not influence the clinical decisions. Although the present study failed to identify the maternal risk factors related to Toxoplasma infection, the results imply that health education is essential, owing to the slightly higher rate of preterm delivery in the IgG seropositive group.

Keywords: Perinatal outcome; Risk factors; Seroprevalence; Southern Taiwan; Toxoplasma.

MeSH terms

  • Antibodies, Protozoan
  • Female
  • Humans
  • Immunoglobulin G
  • Immunoglobulin M
  • Infant
  • Infant, Newborn
  • Male
  • Pregnancy
  • Prenatal Diagnosis
  • Seroepidemiologic Studies
  • Taiwan / epidemiology
  • Toxoplasma* / genetics
  • Toxoplasmosis* / diagnosis
  • Toxoplasmosis* / epidemiology

Substances

  • Antibodies, Protozoan
  • Immunoglobulin G
  • Immunoglobulin M